Watchdog ‘too generous in recommending new drugs’ - The Times 24th August 2007

The National Institute for Health and Clinical Excellence (NICE), which is criticised regularly for being too conservative when it comes to approving new prescription drugs, is in fact too generous with its assessments, a group of economists has suggested. The group argues that, by recommending drugs that save few lives, NICE is diverting money from other, better-value treatments.

Link to Article